Index of artpub/2021/270308/

Blackhall, Fiona
Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC : Results From the Phase 3 TAHOE Study
2021
https://ddd.uab.cat/record/270308